GENEVA, Nov. 30 -- GUANGZHOU CELLPROTEK PHARMACEUTICAL CO., LTD. (G401-415, 3 Lanyue Road, International Business Incubator, Guangzhou Science CityGuangzhou, Guangdong 510663), 广州市赛普特医药科技股份有限公司 (中国广东省广州市科学城揽月路3号广州国际企业孵化器G401-G415) filed a patent application (PCT/CN2025/096195) for "USE OF COMPOSITION CONTAINING MONASCUS AND GINKGO BILOBA EXTRACTS IN HDL-3 REDUCTION" on May 21, 2025. With publication no. WO/2025/242113, the details related to the patent application w...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.